Skip to content

Lemborexant Treatment of Insomnia Linked to Epilepsy

Epilepsy | Sleep

The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* Sleep-related focal epilepsy
* Contraception

Exclusion Criteria:

* Changes in antiseizure medication 1 month before study protocol or during study protocol
* Concomitant medications per SUNRISE1
* Individuals with hepatic impairment
* Female participants who are pregnant or breastfeeding
* Individuals with compromised respiratory function
* Individuals with a history of complex sleep-related behaviour
* Individuals with rare hereditary diseases of galactose intolerance such as galactosemia or glucose-galactose malabsorption
* Individuals with a history of dependence or tolerance - abuse, dependence, rebound insomnia
* Individuals with psychiatric disorders with abnormal thinking and behavioural changes, depression, or suicidal ideation
* Individuals with a diagnosis of narcolepsy

Lieu de l'étude

Health Sciences Centre
Health Sciences Centre
Winnipeg, Manitoba
Canada

Contactez l'équipe d'étude

Primary Contact

Marcus Ng, MD, FRCPC

[email protected]
204-787-2684
Étude parrainée par
University of Manitoba
Participants recherchés
Plus d'informations
ID de l'étude: NCT06262594